Zevenbergen Capital Investments’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-180,828
| Closed | -$21.9M | – | 83 |
|
|
2017
Q1 | $21.9M | Sell |
180,828
-221,532
| -55% | -$26.9M | 1.01% | 35 |
|
|
2016
Q4 | $49.2M | Sell |
402,360
-17,935
| -4% | -$2.19M | 2.32% | 18 |
|
|
2016
Q3 | $51.5M | Buy |
420,295
+75,060
| +22% | +$9.2M | 2.12% | 17 |
|
|
2016
Q2 | $40.3M | Sell |
345,235
-4,445
| -1% | -$519K | 1.89% | 21 |
|
|
2016
Q1 | $48.7M | Sell |
349,680
-1,020
| -0.3% | -$142K | 2.2% | 18 |
|
|
2015
Q4 | $66.9M | Buy |
350,700
+55,305
| +19% | +$10.5M | 2.72% | 14 |
|
|
2015
Q3 | $46.2M | Sell |
295,395
-2,265
| -0.8% | -$354K | 1.98% | 24 |
|
|
2015
Q2 | $53.8M | Buy |
297,660
+36,537
| +14% | +$6.6M | 2.09% | 23 |
|
|
2015
Q1 | $45.3M | Buy |
261,123
+247,091
| +1,761% | +$42.8M | 1.89% | 27 |
|
|
2014
Q4 | $2.6M | Buy |
+14,032
| New | +$2.6M | 0.11% | 43 |
|